Not provided
Not provided
Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 82471973 | Other Grant/Funding Number | National Natural Science Foundation of China | |
| 7242110 | Other Grant/Funding Number | Beijing Natural Science Foundation | |
| 3332025134 | Other Grant/Funding Number | Fundamental Research Funds for the Central Universities |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This is a multi-center, observational study designed to evaluate the discriminative and prognostic value of pressure-volume (PV) loop analysis parameters and myocardial energetics derived from cardiac MRI in patients with heart failure with preserved ejection fraction (HFpEF). This study plans to enroll 3000 adult HFpEF patients and 500 adult healthy controls. The primary clinical endpoint was a composite of all-cause mortality and heart failure hospitalization, with events ascertained through medical records, clinic visits, and telephone follow-up. This study aims to determine whether cardiac MRI-derived PV loop analysis parameters and myocardial energetics provide incremental discriminative and prognostic information beyond conventional cardiac MRI parameters in patients with HFpEF. The study is non-interventional and does not involve any investigational drugs or devices.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| HFpEF patients | Heart failure with preserved ejection fraction (HFpEF) patients | ||
| Healthy controls | Sex- and age-matched healthy controls |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Number of Participants with All-Cause Death | All-cause death was defined as death from any cause occurring during the 3-year follow-up period. Mortality status was ascertained through review of medical records, hospital discharge summaries, and follow-up contacts. | 3-year |
| Measure | Description | Time Frame |
|---|---|---|
| Number of Participants with Cardiovascular Death | Cardiovascular death was defined as death resulting from cardiovascular causes occurring during the 3-year follow-up period. Cardiovascular causes included, but were not limited to, myocardial infarction, heart failure, fatal arrhythmia, stroke, or sudden cardiac death. The outcome was ascertained through review of medical records, hospital discharge summaries, and follow-up contacts. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Patients with heart failure with preserved ejection fraction experienced cardiac MRI scanning
Not provided
Not provided
Not provided
Not provided
| 3-year |
| Number of Participants with Heart Failure Hospitalization | Heart failure hospitalization was defined as any hospitalization for heart failure occurring during the 3-year follow-up period. Hospitalizations were identified based on hospital admission records with a primary diagnosis of heart failure. | 3-year |